Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases...

Endocrine (Springer) 2015 / 12 Vol. 50; Iss. 3

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+CXCR4+cells in patients with type 2 diabetes

Aso, Yoshimasa, Jojima, T., Iijima, T., Suzuki, K., Terasawa, T., Fukushima, M., Momobayashi, A., Hara, K., Takebayashi, K., Kasai, K., Inukai, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
Endocrine
DOI:
10.1007/s12020-015-0688-5
Date:
December, 2015
File:
PDF, 569 KB
english, 2015
Conversion to is in progress
Conversion to is failed